The upstream insight
Circadian clocks coordinate many of the pathways that decline with age.
DeepSense began with a systems-level question: could strengthening biological timing create leverage across multiple healthspan-relevant pathways?
DeepSense began with a systems-level question: could strengthening biological timing create leverage across multiple healthspan-relevant pathways?
The answer is being built step by step through mechanism, material control, delivery, human evidence, digital measurement and commercial partnerships.
ChronoSense® connects the biological hypothesis to delivery, evidence, data and a controlled route to market.
Circadian clocks coordinate many of the pathways that decline with age.
Published nobiletin research created a testable chronobiotic foundation.
Delivery, prodrug chemistry, data and supply extend beyond one ingredient.
A skin proof of concept created an early clinically relevant pathway.
Licensing and co-development enable scale without building every downstream capability in-house.
A complete circadian-medicine ecosystem that learns across products, professionals and data.
The platform is designed to move through explicit stages, with evidence and access appropriate to each one.
Identify the clock-enhancing hypothesis and source material.
Build mechanistic, preclinical, analytical and human evidence.
Develop IP, controlled supply and platform know-how.
License, co-develop and reinvest in the next evidence milestone.
See how the company story becomes an integrated biological, delivery, data and supply architecture.